A Bayesian network meta-analysis of whole brain radiotherapy and stereotactic radiotherapy for brain metastasis.

Xi Yuan,Wen-Jie Liu,Bing Li,Ze-Tian Shen,Jun-shu Shen,Xi-Xu Zhu
DOI: https://doi.org/10.1097/MD.0000000000007698
IF: 1.6
2017-01-01
Medicine
Abstract:This study was conducted to compare the effects of whole brain radiotherapy (WBRT) and stereotactic radiotherapy (SRS) in treatment of brain metastasis. A systematical retrieval in PubMed and Embase databases was performed for relative literatures on the effects of WBRT and SRS in treatment of brain metastasis. A Bayesian network meta-analysis was performed by using the ADDIS software. The effect sizes included odds ratio (OR) and 95% confidence interval (CI). A random effects model was used for the pooled analysis for all the outcome measures, including 1-year distant control rate, 1-year local control rate, 1-year survival rate, and complication. The consistency was tested by using node-splitting analysis and inconsistency standard deviation. The convergence was estimated according to the Brooks-Gelman-Rubin method. A total of 12 literatures were included in this meta-analysis. WBRT+ SRS showed higher 1-year distant control rate than SRS. WBRT+ SRS was better for the 1-year local control rate than WBRT. SRS and WBRT+ SRS had higher 1-year survival rate than the WBRT. In addition, there was no difference in complication among the three therapies. Comprehensively, WBRT+ SRS might be the choice of treatment for brain metastasis.
What problem does this paper attempt to address?